MedTrace Logo

Clinical Trial to Determine the Bioavailability of Three Different Zinc Preparations

NCT02292303 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2018-06-12

No results posted yet for this study

Summary

The main objective of this clinical is to get information on pharmacokinetics of zinc-enriched yeast.The bioavailability of the yeast enriched with zinc will be compared to two selected zinc salts used in food supplements that are zinc oxide and zinc gluconate.

Conditions

  • Zinc Deficiency

Interventions

DIETARY_SUPPLEMENT

zinc-enriched yeast

DIETARY_SUPPLEMENT

Zinc references

Sponsors & Collaborators

  • Lesaffre International

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2014-12-31
Completion
2015-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02292303 on ClinicalTrials.gov